These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6458120)

  • 1. Selective action of alpha 2-macroglobulin-plasmin complex fibrin.
    Veremeenko KN; Kizim AI
    Thromb Res; 1981 Aug; 23(3):317-22. PubMed ID: 6458120
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
    Summaria L; Boreisha IG; Arzadon L; Robbins KC
    Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmin digestion of stabilized and non-stabilized fibrin illustrated by immunoelectrophoresis and haemagglutination inhibition immuno assays.
    Feddersen C; Gormsen J
    Scand J Haematol; 1971; 8(6):461-9. PubMed ID: 4258528
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of SK-human plasmin, SK-dog plasmin complexes with alpha 2-antiplasmin and alpha 2-macroglobulin.
    Reddy KN; Cercek B; Lew AS; Ganz W
    Thromb Res; 1986 Mar; 41(5):671-80. PubMed ID: 2421434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
    Anonick PK; Gonias SL
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen-fibrin breakdown products in pathologic synovial fluids. An immunologic study.
    Gormsen J; Andersen RB; Feddersen C
    Arthritis Rheum; 1971; 14(4):503-12. PubMed ID: 4254709
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolysis of soluble and polymerized des-AA/des-AABB fibrin compared to fibrinogenolysis in buffer and in fibrinogen-boosted serum. Evidence that plasminogen activators are responsible for preferential degradation of polymerized fibrin.
    Brosstad F
    Thromb Res; 1979; 15(3-4):497-504. PubMed ID: 158847
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the proteolysis of fibrinogen and fibrin by Aspergillus ochraceus enzyme as compared to the action of plasmin.
    Teisseyre E; Latallo ZS; Kopeć M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):99-110. PubMed ID: 4134484
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of streptokinase on the fibrin binding site of plasmin(ogen).
    Cederholm-Williams SA
    Thromb Res; 1981 Mar; 21(6):649-54. PubMed ID: 6455776
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha 2-plasmin inhibitor deficiency.
    Lipinski B; Gurewich V
    Lancet; 1979 Feb; 1(8111):329. PubMed ID: 84984
    [No Abstract]   [Full Text] [Related]  

  • 13. [On thrombolysis with various thrombolytic agents. I. Studies on experimental human natural blood clots].
    Schmidt HW
    Klin Wochenschr; 1966 Jun; 44(11):618-21. PubMed ID: 4229084
    [No Abstract]   [Full Text] [Related]  

  • 14. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A method for determining plasmin by the rate of fibrin gel lysis].
    Popova GIu; Eremeev NL; Aĭsina RB; Kazanskaia NF
    Biull Eksp Biol Med; 1989 May; 107(5):561-4. PubMed ID: 2525408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
    Khavkina LS; Rozenfeld MA; Leonova VB
    Thromb Res; 1995 Apr; 78(2):173-87. PubMed ID: 7482434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal clumping with soluble fibrin mmonomer complexes.
    Lipiński B; Hawiger J; Jeljaszewicz J
    J Exp Med; 1967 Nov; 126(5):979-88. PubMed ID: 4228857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y; Iwamoto M
    Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
    [No Abstract]   [Full Text] [Related]  

  • 19. The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.
    Takada Y; Takada A
    Thromb Res; 1989 Apr; 54(2):133-9. PubMed ID: 2526391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of 2 -macroglobulin in bovine plasma. 3. Its actions on bovine plasma kallikrein, plasmin and thrombin.
    Sugihara H; Nagasawa S; Suzuki T
    J Biochem; 1971 Oct; 70(4):649-58. PubMed ID: 4257424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.